The traditional way of evaluating point solutions in digital health benefits is to ask whether they reduce spend inside their own category. While that remains a fair question, it is no longer enough.

Benefits leaders are being asked to solve for bigger goals: lower healthcare cost trends, better employee experience, fewer avoidable escalations, and more value across the population. If an MSK benefit can only affect MSK claims, it stays in a silo. If it can also bend total medical spend for people managing comorbidities like hypertension, heart disease, or diabetes, it becomes much more strategically relevant.

For employers, this matters because some of the most expensive employees are not people with a single condition. They are people dealing with overlapping needs. A benefit that helps them move earlier, avoid escalation, and reduce avoidable care may create value far beyond a single line item in the claims file.

Lower spending across your population

At ISPOR (the leading professional society for health economics and outcomes research), Hinge Health presented an abstract on the impact of a digital musculoskeletal program on healthcare spending among people with chronic MSK pain and common comorbidities like hypertension, heart disease and diabetes. The analysis used medical claims from a HIPAA-compliant commercial database of more than 100 million U.S. adults and compared Hinge Health participants with matched nonparticipants over 12 months. Participants were matched on demographics, comorbidities, and baseline MSK-related utilization and costs.

The headline finding is important for any employer or health plan trying to reduce population-wide spend, not just MSK spend: Hinge Health participants had significantly lower total medical spending than nonparticipants.

What the new comorbidity data shows

On average, Hinge Health participants in the study had $2,867 lower total medical costs per member per year. 

The comorbidity findings are especially relevant for benefit leaders focused on high-prevalence, high-cost chronic conditions:

  • Among participants with hypertension, Hinge Health was associated with $2,553 lower overall medical spend.

  • Among participants with heart disease, Hinge Health was associated with $2,525 lower overall medical spend.

  • Among participants with diabetes, Hinge Health was associated with $3,523 lower overall medical spend.

This is because when employees are dealing with chronic conditions, MSK pain is rarely just an isolated issue. It can make it harder to stay active, harder to stay engaged in care, and harder to control downstream costs. For benefits leaders, that raises an important question: if you are investing in broader population health, are you also investing in one of the biggest barriers to making that strategy work?

This new Hinge Health claims data suggests you should be.

That is what makes this analysis so meaningful. It suggests that MSK care can play a role in a broader chronic condition strategy, especially for populations where pain and physical limitation may complicate the management of other ongoing health needs.

A stronger way to think about MSK ROI

This comorbidity abstract also builds on a broader pattern in Hinge Health’s claims evidence.

In a separate 2026 multi-employer claims analysis across 203,518 participants from 916 employers and 23 industries, Hinge Health reported 3.0x ROI and $2,941 in average MSK savings per member per year, with more than half of savings driven by surgery avoidance.

In a 2025 fully insured claims study, Hinge Health reported 2.4x ROI and $2,343 in per-member MSK savings, with lower spend across all MSK categories and 44% of savings coming from lower surgery costs.

Taken together, the story is becoming clearer. Hinge Health is not just showing clinical improvement. It is building a growing claims-based evidence base that links better MSK care to lower utilization and lower spend in real-world populations.

What benefit leaders should take away

  • MSK pain undermines outcomes and raises costs: it limits function and engagement and speeds entry into higher-cost care pathways.

  • Integrate MSK into your chronic-condition strategy: if hypertension, heart disease, or diabetes are priorities, MSK belongs in the same conversation.

  • Population-wide impact: reducing MSK pain can enable better health, stronger engagement, and lower total cost of care across your workforce.

References

  1. Yadav S. Impact of a digital musculoskeletal program on healthcare spending among participants with chronic musculoskeletal pain and comorbidities. (2025). Value in Health, Volume 28, Issue S1. 2025-05, ISPOR 2025, Montréal, Quebec, CA. (n = 11,846) https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-2025/poster-session-3/impact-of-a-digital-musculoskeletal-program-on-healthcare-spending-among-participants-with-chronic-musculoskeletal-pain-and-comorbidities
  2. In a control-matched medical claims analysis of 203,518 commercially insured adults across 916 employers in 23 industries, Hinge Health compared 101,759 Hinge Health members with 101,759 matched controls receiving traditional conservative musculoskeletal care. Using a difference-in-differences analysis of 12-month pre/post MSK cost changes, Hinge Health members had 69% fewer surgeries than matched controls, with lower surgery costs accounting for 52% of total savings, or $1,139 per member.(n=203,518)
  3. Fully Insured ROI Study, 2025. (n=4,788)